Health care has had a tough year. Where we stand on our 5 stocks in the sector

[ad_1] There’s Eli Lilly (LLY), and then there’s everybody else. That’s a simple way to describe…

Analysts predicted new obesity medicines would be blockbusters. Now they’re raising their forecasts

[ad_1] As new weight loss medications garnered buzz last year, analysts’ forecasts signaled these drugs would…

Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here’s what we know

[ad_1] An Ozempic (semaglutide) injection pen is seen on a kitchen table in Riga, Latvia on…

‘Robot pills’ could one day help patients avoid needles. The stocks are cheap, but risky

[ad_1] Ask most patients if they prefer to receive medicine by swallowing a pill, by injection…

Weight loss drugs boost sales at retail pharmacies, but they may not help profits much

[ad_1] A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2…

Here are some of the companies saying weight loss drugs could impact their business

[ad_1] The impact of new weight loss treatments is being felt well beyond the health-care industry…

Activists ease up on Salesforce — plus, 10 other Club stocks traded by Wall Street pros

[ad_1] The extraordinary activist-investor interest in Salesforce (CRM) eased further in the second quarter, according to…

Here’s what is behind the stock market’s sell-off and what we’re doing about it

[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at…

Stocks making the biggest moves premarket: UPS, Lucid, Beyond Meat, Novo Nordisk and more

[ad_1] A UPS worker checks an Amazon box to be delivered in New York. Eduardo Munoz…

Novavax shares jump after Covid vaccine maker posts surprise quarterly profit

[ad_1] Medical syringes and Novavax logo displayed in the background are seen in this illustration photo…

Here are the 5 price-target changes and 4 trades we made during this busy earnings week

[ad_1] In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets…

These health-care companies see opportunity ahead from Alzheimer’s drug approval

[ad_1] As patients with Alzheimer’s disease seek out a newly approved treatment, they will need MRIs,…

This under-the-radar biotech could be the next way to play the obesity drug boom

[ad_1] The lucrative market for obesity drugs is dominated by two players right now, but Structure…

Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials

[ad_1] The Eli Lilly logo is shown on one of the company’s offices in San Diego,…

Medicare proposes removing limit on PET scans used to help diagnose Alzheimer’s disease

[ad_1] Jay Reinstein, who suffers from Alzheimer’s, sits on a bed after receiving a PET scan…

Newseum Global